Merck Cholesterol Drug Fails in Study

Published December 20, 2012

Merck Cholesterol Drug Fails in Study

Filed under: residential drug treatment programs

Merck also recently discontinued a partnership with a South Korean drug maker to develop a biosimilar competitor to Enbrel, the blockbuster arthritis treatment made by Amgen Inc. and Pfizer, a spokesman confirmed. Merck's cholesterol franchise, which …
Read more on Wall Street Journal

New York Times Ad: 'Prohibition is Finally Coming to an End'

Filed under: residential drug treatment programs

As a result of their work, hundreds of thousands of people have been diverted from incarceration to drug treatment programs, hundreds of thousands of sick and dying patients can safely access their medicine without being considered criminals under the …
Read more on San Francisco Chronicle (blog)

2012 Review: Celgene

Filed under: residential drug treatment programs

Probably the most eagerly anticipated results stemmed from a phase 3 trial of the drug in treating prostate cancer, which has one of the lowest survival rates among the various types of cancer. Celgene didn't disappoint. In November, the company stated …
Read more on DailyFinance